Lawyers.com Supervising Producer John McCarthy interviews attorney Hunter Shkolnik, an expert on Actos litigation. He describes Actos as a “blockbuster” drug: It has netted its manufacturer tens of billions of dollars and is one of the 10 most
Read full story
Related posts:
- Actos Diabetes Drug Increases Cancer Ris Supervising producer John McCarthy speaks with attorney Hunter Shkolnik who...
- Lawsuits Allege Actos Drug Linked To Increased Bladder Cancer Risk Climaco, Wilcox, Peca, Tarantino & Garofoli Co., LPA has filed...
- Diabetes Drug Actos French Claim Cancer Risk The French drug regulatory authority has suspended use of the...
- Actos Label Updated To Warn For Increased Risk Of Bladder Cancer The blockbuster diabetes medication Actos has faced harsh criticism in...
- Diabetes Drug Actos May Increase Risk Of Bladder Cancer Actos (pioglitazone as the single ingredient) is a prescription medication...